CD8A and neoplasm: Specifically, this antitumor immunity occurs in the form of reduced accumulation of myeloid-derived suppressor cells in the tumor (178), promotion of CD8+ T cell expansion (179), expansion of antigen-specific T cell responses (180), and reduction in tumor growth in non-irradiated tumor sites (181).